Sionna Therapeutics (NASDAQ:SION) Trading Down 3.5% – Should You Sell?

Sionna Therapeutics, Inc. (NASDAQ:SION)’s share price was down 3.5% on Friday . The stock traded as low as $16.14 and last traded at $16.50. Approximately 11,425 shares traded hands during mid-day trading, a decline of 95% from the average daily volume of 208,577 shares. The stock had previously closed at $17.10.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Guggenheim initiated coverage on Sionna Therapeutics in a research report on Tuesday, March 4th. They issued a “buy” rating and a $45.00 price target on the stock. TD Cowen assumed coverage on shares of Sionna Therapeutics in a research note on Tuesday, March 4th. They issued a “buy” rating on the stock. Finally, Stifel Nicolaus started coverage on shares of Sionna Therapeutics in a research report on Tuesday, March 4th. They set a “buy” rating and a $32.00 price objective for the company.

Sionna Therapeutics Trading Down 12.4 %

Sionna Therapeutics Company Profile

We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients.